174 related articles for article (PubMed ID: 1552500)
81. Design, synthesis, biological evaluation and molecular modeling study of novel macrocyclic bisbibenzyl analogues as antitubulin agents.
Sun B; Li L; Hu QW; Zheng HB; Tang H; Niu HM; Yuan HQ; Lou HX
Eur J Med Chem; 2017 Mar; 129():186-208. PubMed ID: 28222318
[TBL] [Abstract][Full Text] [Related]
82. Antitumor agents. 141. Synthesis and biological evaluation of novel thiocolchicine analogs: N-acyl-, N-aroyl-, and N-(substituted benzyl)deacetylthiocolchicines as potent cytotoxic and antimitotic compounds.
Sun L; Hamel E; Lin CM; Hastie SB; Pyluck A; Lee KH
J Med Chem; 1993 May; 36(10):1474-9. PubMed ID: 8496915
[TBL] [Abstract][Full Text] [Related]
83. Antimitotic activity of diaryl compounds with structural features resembling combretastatin A-4.
Aleksandrzak K; McGown AT; Hadfield JA
Anticancer Drugs; 1998 Jul; 9(6):545-50. PubMed ID: 9877243
[TBL] [Abstract][Full Text] [Related]
84. Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity.
Ducki S; Rennison D; Woo M; Kendall A; Chabert JF; McGown AT; Lawrence NJ
Bioorg Med Chem; 2009 Nov; 17(22):7698-710. PubMed ID: 19837593
[TBL] [Abstract][Full Text] [Related]
85. Synthesis and evaluation of a series of benzylaniline hydrochlorides as potential cytotoxic and antimitotic agents acting by inhibition of tubulin polymerization.
Cushman M; He HM; Lin CM; Hamel E
J Med Chem; 1993 Sep; 36(19):2817-21. PubMed ID: 8410995
[TBL] [Abstract][Full Text] [Related]
86. Structure-function studies with derivatives of 6-benzyl-1,3-benzodioxole, a new class of synthetic compounds which inhibit tubulin polymerization and mitosis.
Batra JK; Jurd L; Hamel E
Mol Pharmacol; 1985 Jan; 27(1):94-102. PubMed ID: 3965931
[TBL] [Abstract][Full Text] [Related]
87. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
[TBL] [Abstract][Full Text] [Related]
88. Antitumor agents. 155. Synthesis and biological evaluation of 3',6,7-substituted 2-phenyl-4-quinolones as antimicrotubule agents.
Li L; Wang HK; Kuo SC; Wu TS; Mauger A; Lin CM; Hamel E; Lee KH
J Med Chem; 1994 Sep; 37(20):3400-7. PubMed ID: 7932568
[TBL] [Abstract][Full Text] [Related]
89. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
Hall JJ; Sriram M; Strecker TE; Tidmore JK; Jelinek CJ; Kumar GD; Hadimani MB; Pettit GR; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem Lett; 2008 Sep; 18(18):5146-9. PubMed ID: 18710804
[TBL] [Abstract][Full Text] [Related]
90. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site.
Liu YN; Wang JJ; Ji YT; Zhao GD; Tang LQ; Zhang CM; Guo XL; Liu ZP
J Med Chem; 2016 Jun; 59(11):5341-55. PubMed ID: 27172319
[TBL] [Abstract][Full Text] [Related]
91. Synthesis and biological evaluation of 1,2,3-triazole linked aminocombretastatin conjugates as mitochondrial mediated apoptosis inducers.
Kamal A; Shaik B; Nayak VL; Nagaraju B; Kapure JS; Shaheer Malik M; Shaik TB; Prasad B
Bioorg Med Chem; 2014 Oct; 22(19):5155-67. PubMed ID: 25192811
[TBL] [Abstract][Full Text] [Related]
92. Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules.
Bai R; Friedman SJ; Pettit GR; Hamel E
Biochem Pharmacol; 1992 Jun; 43(12):2637-45. PubMed ID: 1632820
[TBL] [Abstract][Full Text] [Related]
93. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
[TBL] [Abstract][Full Text] [Related]
94. 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
J Med Chem; 2006 Dec; 49(26):7816-25. PubMed ID: 17181164
[TBL] [Abstract][Full Text] [Related]
95. Synthesis of a 2-aryl-3-aroyl indole salt (OXi8007) resembling combretastatin A-4 with application as a vascular disrupting agent.
Hadimani MB; Macdonough MT; Ghatak A; Strecker TE; Lopez R; Sriram M; Nguyen BL; Hall JJ; Kessler RJ; Shirali AR; Liu L; Garner CM; Pettit GR; Hamel E; Chaplin DJ; Mason RP; Trawick ML; Pinney KG
J Nat Prod; 2013 Sep; 76(9):1668-78. PubMed ID: 24016002
[TBL] [Abstract][Full Text] [Related]
96. Podophyllotoxin, steganacin and combretastatin: natural products that bind at the colchicine site of tubulin.
Sackett DL
Pharmacol Ther; 1993 Aug; 59(2):163-228. PubMed ID: 8278462
[TBL] [Abstract][Full Text] [Related]
97. Synthesis and tubulin binding of novel C-10 analogues of colchicine.
Staretz ME; Hastie SB
J Med Chem; 1993 Mar; 36(6):758-64. PubMed ID: 8459402
[TBL] [Abstract][Full Text] [Related]
98. The synthesis and evaluation of temperature sensitive tubulin toxins.
Miller TA; Bulman AL; Thompson CD; Macdonald TL
Bioorg Med Chem Lett; 1999 Feb; 9(3):407-12. PubMed ID: 10091693
[TBL] [Abstract][Full Text] [Related]
99. Inhibitory activity of diarylamidine derivatives on murine leukemia L1210 cell growth.
Balzarini J; de Clercq E; Dann O
Invest New Drugs; 1983; 1(2):103-15. PubMed ID: 6678860
[TBL] [Abstract][Full Text] [Related]
100. Structural requirements for the interaction of combretastatins with tubulin: how important is the trimethoxy unit?
Gaukroger K; Hadfield JA; Lawrence NJ; Nolan S; McGown AT
Org Biomol Chem; 2003 Sep; 1(17):3033-7. PubMed ID: 14518125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
